Seeking a cure and improving quality of life for those who live with multiple sclerosis.
Multiple Sclerosis is a chronic and often debilitating disease of the central nervous system that affects 400,000 people in the United States. The Foundation believes that encouraging innovative research on MS is vital to understanding the causes of the disease, developing effective treatments, and eventually a cure. At the same time, the Foundation realizes that those currently living with MS deserve services that will help them retain their best quality of life.
News from the Field
Nominations are now open for the Marilyn Hilton Award for Innovation in Multiple Sclerosis Research. The goal of the award is to stimulate innovative and potentially paradigm-shifting research on Progressive Multiple Sclerosis (MS), which may otherwise go unfunded in times of fiscal restraint.
To establish a disability specific pipeline to develop generic, inexpensive neuroprotective drugs to halt progression of specific disabilities related to MS
Stay connected and sign up for our newsletter